Literature DB >> 1381348

Insulin and insulinomimetic agents induce activation of phosphatidylinositol 3'-kinase upon its association with pp185 (IRS-1) in intact rat livers.

Y R Hadari1, E Tzahar, O Nadiv, P Rothenberg, C T Roberts, D LeRoith, Y Yarden, Y Zick.   

Abstract

The major cytosolic substrate of the insulin receptor is a 185-kDa phosphoprotein (IRS-1) that contains multiple putative attachment sites for the p85 alpha regulatory subunit of phosphatidylinositol 3'-kinase (PI3K). To examine the possible interaction of pp185 with p85 alpha in vivo, we injected insulin or insulinomimetic agents (a combination of H2O2 and vanadate (H/V)) into the portal vein of anesthetized rats. IN this model system, H/V treatment and, to a lesser extent, injection of insulin resulted in rapid and sustained tyrosine phosphorylation of multiple cellular proteins, including pp185/IRS-1. The latter was found to undergo specific association with the p85 alpha regulatory subunit of PI3K but not with two other proteins that contain src homology domains. As p85 alpha was not detectably phosphorylated on tyrosine residues and did not appear to interact directly with the insulin receptor, we conclude that tyrosine phosphorylation of pp185 promotes its association with p85 alpha and the catalytic subunit of PI3K. The recruitment of the holoenzyme may also involve its enzymatic activation and thus constitute an important step in the transduction of insulin signals.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1381348

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Oxidative stress impairs insulin but not platelet-derived growth factor signalling in 3T3-L1 adipocytes.

Authors:  A Tirosh; A Rudich; R Potashnik; N Bashan
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

2.  Inhibition of clathrin-mediated endocytosis selectively attenuates specific insulin receptor signal transduction pathways.

Authors:  B P Ceresa; A W Kao; S R Santeler; J E Pessin
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

Review 3.  Insulin receptor/IRS-1/PI 3-kinase signaling system in corticosteroid-induced insulin resistance.

Authors:  F Folli; M J Saad; C R Kahn
Journal:  Acta Diabetol       Date:  1996-09       Impact factor: 4.280

4.  Differential effects of IRS1 phosphorylated on Ser307 or Ser632 in the induction of insulin resistance by oxidative stress.

Authors:  A Bloch-Damti; R Potashnik; P Gual; Y Le Marchand-Brustel; J F Tanti; A Rudich; N Bashan
Journal:  Diabetologia       Date:  2006-08-03       Impact factor: 10.122

Review 5.  Peroxovanadium compounds: biological actions and mechanism of insulin-mimesis.

Authors:  A P Bevan; P G Drake; J F Yale; A Shaver; B I Posner
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

Review 6.  New insights into protein-tyrosine kinase receptor signaling complexes.

Authors:  M J Fry; G Panayotou; G W Booker; M D Waterfield
Journal:  Protein Sci       Date:  1993-11       Impact factor: 6.725

7.  Association of the insulin receptor and phosphatidylinositol 3-kinase requires a third component.

Authors:  R Liu; J N Livingston
Journal:  Biochem J       Date:  1994-01-15       Impact factor: 3.857

8.  The prolyl peptidases PRCP/PREP regulate IRS-1 stability critical for rapamycin-induced feedback activation of PI3K and AKT.

Authors:  Lei Duan; Guoguang Ying; Brian Danzer; Ricardo E Perez; Zia Shariat-Madar; Victor V Levenson; Carl G Maki
Journal:  J Biol Chem       Date:  2014-06-16       Impact factor: 5.157

9.  Transcriptome correlation analysis identifies two unique craniosynostosis subtypes associated with IRS1 activation.

Authors:  B D Stamper; B Mecham; S S Park; H Wilkerson; F M Farin; R P Beyer; T K Bammler; L M Mangravite; M L Cunningham
Journal:  Physiol Genomics       Date:  2012-10-16       Impact factor: 3.107

10.  Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus.

Authors:  F Folli; M J Saad; J M Backer; C R Kahn
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.